You are here: Home
Treating Cancer with Light

Treating Cancer with Light

New LED Device May Help Advance Photodynamic Therapy for Skin Cancer. Scientists at the University of California, Irvine (UC Irvine), believe so. They're explo...

Exploring Opportunities in Chemical Biology

Interview with: Torsten Hoffmann, Head Discovery Chemistry, F. Hoffmann – La Roche
Drug discovery scientists need to broaden their approaches to pharmaceutical...

Maximising Drug Discovery Research

Interview with: Teodor Aastrup, Chief Executive Officer, Attana AB
"Drug discovery scientists should focus on the biological relevance of their candidate molec...

Banner

Knowledge Bank

Edit

Amount of short articles:

Amount of articles links:

You can order sections with dragging on list bellow:

  • Knowledge Bank
  • Business & Industry
Save
Cancel
Reset

News

New suppliers to ease 2 cancer drug

Federal regulators said Tuesday that they've approved new suppliers for two crucial cancer drugs, easing critical shortages - at least for the time being - that have patients worried about

Tuesday, 21 February 2012 Comments

Press Releases

ELC Group launches new software subsidiary Pharma eReport to provide complete EVMPD compliance

ELC Group, the pan-European pharmaceutical regulatory affairs organisation, today announces the launch of a new subsidiary, Pharma eReport – a software and services company that delivers a comprehensive EVMPD compliance so

Tuesday, 21 February 2012 Comments

Research Insight

Warfarin and aspirin are similar in heart failure treatment

In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin and aspirin were similar in preventing deaths and strokes in heart failure patients with normal heart rhythm, according

Monday, 6 February 2012 Comments

Techno Trends

Medicago to develop new VLP vaccine candidate for

Medicago, a biotechnology company, has completed initial studies towards the development of a new VLP vaccine candidate for ra

Friday, 20 January 2012 Comments

Industry Reports

Pfizer reports fourth-quarter and full-year 2011

  Pfizer Inc. reported financial results for fourth-quarter and full-year 2011. Fourth-quarter 2011 revenues were $16.7 billion, a decrease of 4% compared with $17.4 billion in the year-ago quarter, which reflects an operational

Wednesday, 1 February 2012 Comments

Articles

Why streamlining pharma supply chain is

For most pharmaceuticals executives, the prospect of the patent cliff is looming large in their thoughts. But an additional – and less obvious – challenge is also ready to derail

Wednesday, 18 May 2011 Comments

Business & Industry

Edit

Amount of short articles:

Amount of articles links:

You can order sections with dragging on list bellow:

  • Knowledge Bank
  • Business & Industry
Save
Cancel
Reset

Drug Research

APP Pharmaceuticals receives marketing approval for Methotrexate

APP Pharmaceuticals, a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals, has received FDA approval to market preservative-free Methotrexate Injection, US

Tuesday, 21 February 2012 Comments

Production & Manufacturing

EMA approves Genzyme Framingham manufacturing

The European Medicines Agency (EMA) has approved Genzyme’s manufacturing plant in Framingham, Massachusetts, US for the production of Fabrazyme (agalsidase be

Thursday, 19 January 2012 Comments

Packaging & Labelling

FDA approves TYSABRI label

Biogen Idec and Elan have announced the FDA approval of a product label change for TYSABRI that will help enable individual benefit risk assessment for patients with multiple sclerosis (M

Monday, 23 January 2012 Comments

Strategy

OncoMed Pharmaceuticals and Bayer HealthCare Expand Cancer Stem Cell Collaboration with Clinical Manufacturing

OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics targeting cancer stem cells, today announced it has expanded its collaboration with Bayer HealthCare. Bayer’s U.S. affiliate will manufacture clinical supplies of

Thursday, 21 April 2011 Comments

Clinical Trials

Galena initiates Phase III PRESENT trial for

Galena Biopharma has initiated Phase III trial for NeuVax (E75 peptide plus GM-CSF) vaccine in HER2 1+ and 2+ breast cancer patients in the adjuvant setting to prevent re

Monday, 23 January 2012 Comments

IT & Data Management

Zynx supplies Prime-A-Pump tool to US medical center

Brigham and Women's Hospital in Boston, US, has selected Zynx Health Device Network's Prime-A-Pump, a Web-based knowledge resource and collaboration tool intended to maintain smart pump drug li

Friday, 20 January 2012 Comments

Banner